ArticleBrain communications2023

The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy.

Christopher R S Banerji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.